Given that RTK coactivation plays an important role in tumor response to RTK-targeted therapy (19,29,34), we sought to use molecular imaging to understand and visualize the interplay between MET, EGFR, and HER2 receptor dynamics in our PDX model, which expresses all 3 receptors. Here, MET is linked to neoplasm.